Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Clinical Study to Evaluate the Safety and Cytodynamic Characteristics of RGL-305 in Patients With Lymphoma

NCT07006012 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07006012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07006012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Clinical Study to Evaluate the Safety and Cytodynamic Characteristics of RGL-305 in Patients With Lymphoma
Lead sponsor
Fudan University
Phase
Not applicable
Overall status
Recruiting
Start date
April 21, 2025
Completion date
December 31, 2031
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma patients with complete response (cr) or partial response (pr) after standard treatment had a positive minimal residual lesion (mrd)